XTX Topco’s Neuronetics STIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$286K Buy
220,323
+74,168
+51% +$108K ﹤0.01% 2964
2026
Q1
$212K Sell
146,155
-168,039
-53% -$266K ﹤0.01% 2804
2025
Q4
$434K Buy
314,194
+285,438
+993% +$597K 0.01% 1732
2025
Q3
$78.5K Buy
+28,756
New +$102K ﹤0.01% 2075
2025
Q1
Sell
-30,689
Closed -$49.4K 3072
2024
Q4
$49.4K Buy
+30,689
New +$31.9K ﹤0.01% 1898
2024
Q2
Sell
-11,846
Closed -$56.4K 2439
2024
Q1
$56.4K Sell
11,846
-34,636
-75% -$122K 0.01% 1453
2023
Q4
$135K Sell
46,482
-36,997
-44% -$58.3K 0.03% 1063
2023
Q3
$113K Sell
83,479
-28,888
-26% -$50.6K 0.02% 1171
2023
Q2
$242K Sell
112,367
-33,434
-23% -$81.1K 0.04% 876
2023
Q1
$424K Buy
145,801
+101,083
+226% +$510K 0.09% 397
2022
Q4
$307K Buy
+44,718
New +$211K 0.07% 568
2021
Q4
Sell
-16,716
Closed -$110K 982
2021
Q3
$110K Buy
+16,716
New +$160K 0.04% 553

Other funds holding STIM

XTX Topco's STIM Position: Q2 2026 in Review

XTX Topco increased its Neuronetics (STIM) stake by 51% in Q2 2026, buying an estimated $108K and bringing the position to 220,323 shares worth $286K. The position accounts for ﹤0.01% of the portfolio, ranked #2964.

XTX Topco first reported a position in STIM in Q3 2021 and has held it in 12 quarters since. The position peaked at $434K in Q4 2025. 86 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

  • XTX Topco held 220,323 shares of Neuronetics worth $286K as of Q2 2026.
  • XTX Topco bought 74,168 Neuronetics shares in Q2 2026, an estimated $108K.
  • Neuronetics made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #2964 holding.
  • XTX Topco first reported a position in Neuronetics in Q3 2021 and has held it in 12 quarters since.
  • XTX Topco's Neuronetics position peaked at $434K in Q4 2025.
  • 86 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.